| Item Number | Description | Schedule Fee |
|---|---|---|
| 61646 | Whole body FDG PET study for the evaluation of patients with suspected residual or recurrent sarcoma (excluding gastrointestinal stromal tumour) after the initial course of definitive therapy to determine suitability for subsequent therapy with curative intent. (R) |
$999.00 |
| Total: | $999.00 | |